104 related articles for article (PubMed ID: 20557364)
21. Cost-effectiveness of screening, surveillance, and primary prophylaxis strategies for esophageal varices.
Arguedas MR; Heudebert GR; Eloubeidi MA; Abrams GA; Fallon MB
Am J Gastroenterol; 2002 Sep; 97(9):2441-52. PubMed ID: 12358270
[TBL] [Abstract][Full Text] [Related]
22. An economic analysis of endoscopic ablative therapy for management of nondysplastic Barrett's esophagus.
Das A; Wells C; Kim HJ; Fleischer DE; Crowell MD; Sharma VK
Endoscopy; 2009 May; 41(5):400-8. PubMed ID: 19418393
[TBL] [Abstract][Full Text] [Related]
23. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
24. Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies.
Spiegel BM; Ofman JJ; Woods K; Vakil NB
Am J Gastroenterol; 2003 Jan; 98(1):86-97. PubMed ID: 12526942
[TBL] [Abstract][Full Text] [Related]
25. Screening for oesophageal adenocarcinoma: an evaluation of a surveillance program for columnar metaplasia of the oesophagus.
Nilsson J; Skobe V; Johansson J; Willén R; Johnsson F
Scand J Gastroenterol; 2000 Jan; 35(1):10-6. PubMed ID: 10672828
[TBL] [Abstract][Full Text] [Related]
26. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
27. [Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?].
Remes-Troche JM; Ramírez-Arias JF; Gómez-Escudero O; Valdovinos-Andraca F; Vargas-Vorácková F
Rev Gastroenterol Mex; 2006; 71(1):46-54. PubMed ID: 17061478
[TBL] [Abstract][Full Text] [Related]
28. Patterns of endoscopy in the United States: analysis of data from the Centers for Medicare and Medicaid Services and the National Endoscopic Database.
Sonnenberg A; Amorosi SL; Lacey MJ; Lieberman DA
Gastrointest Endosc; 2008 Mar; 67(3):489-96. PubMed ID: 18179793
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness analysis of management strategies for obscure GI bleeding.
Gerson L; Kamal A
Gastrointest Endosc; 2008 Nov; 68(5):920-36. PubMed ID: 18407270
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.
Kwon JS; Lu KH
Obstet Gynecol; 2008 Jul; 112(1):56-63. PubMed ID: 18591308
[TBL] [Abstract][Full Text] [Related]
31. Screening for gastric cancer and surveillance of premalignant lesions: a systematic review of cost-effectiveness studies.
Areia M; Carvalho R; Cadime AT; Rocha Gonçalves F; Dinis-Ribeiro M
Helicobacter; 2013 Oct; 18(5):325-37. PubMed ID: 23566268
[TBL] [Abstract][Full Text] [Related]
32. The Clinical Impact and Cost-Effectiveness of Surveillance of Incidentally Detected Gastric Intestinal Metaplasia: A Microsimulation Analysis.
Thiruvengadam NR; Gupta S; Buller S; Awad I; Gandhi D; Ibarra A; Latorre G; Riquelme A; Kochman ML; Cote G; Shah SC; Saumoy M
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):51-61. PubMed ID: 37302442
[TBL] [Abstract][Full Text] [Related]
33. Determining the cost-effectiveness of endoscopic surveillance for gastric cancer in patients with precancerous lesions.
Wu JT; Zhou J; Naidoo N; Yang WY; Lin XC; Wang P; Ding JQ; Wu CB; Zhou HJ
Asia Pac J Clin Oncol; 2016 Dec; 12(4):359-368. PubMed ID: 27452189
[TBL] [Abstract][Full Text] [Related]
34. Comparing endoscopy and upper gastrointestinal X-ray for gastric cancer screening in South Korea: a cost-utility analysis.
Chang HS; Park EC; Chung W; Nam CM; Choi KS; Cho E; Cho WH
Asian Pac J Cancer Prev; 2012; 13(6):2721-8. PubMed ID: 22938448
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.
Yeh JM; Hur C; Kuntz KM; Ezzati M; Goldie SJ
Cancer; 2010 Jun; 116(12):2941-53. PubMed ID: 20564399
[TBL] [Abstract][Full Text] [Related]
36. Biennial Endoscopic Surveillance of Gastrointestinal Metaplasia and Its Subtypes Reduces Gastric Cancer Mortality and Is Cost-Effective in a Markov State Transition Model.
Becker EC; Salunke R; Saraceni C; Birk J
South Med J; 2023 Dec; 116(12):951-956. PubMed ID: 38051169
[TBL] [Abstract][Full Text] [Related]
37. International cost-effectiveness analysis evaluating endoscopic screening for gastric cancer for populations with low and high risk.
Ascherman B; Oh A; Hur C
Gastric Cancer; 2021 Jul; 24(4):878-887. PubMed ID: 33595744
[TBL] [Abstract][Full Text] [Related]
38. Interobserver variability and accuracy of high-definition endoscopic diagnosis for gastric intestinal metaplasia among experienced and inexperienced endoscopists.
Hyun YS; Han DS; Bae JH; Park HS; Eun CS
J Korean Med Sci; 2013 May; 28(5):744-9. PubMed ID: 23678267
[TBL] [Abstract][Full Text] [Related]
39. Follow-up of intestinal metaplasia in the stomach: When, how and why.
Zullo A; Hassan C; Romiti A; Giusto M; Guerriero C; Lorenzetti R; Campo SM; Tomao S
World J Gastrointest Oncol; 2012 Mar; 4(3):30-6. PubMed ID: 22468181
[TBL] [Abstract][Full Text] [Related]
40. Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States.
Shah SC; Canakis A; Peek RM; Saumoy M
Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3026-3039. PubMed ID: 32707341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
